Date: 2025/04/02 - 23:00
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/28 - 12:00
People with inflammatory bowel disease (IBD) or Parkinson’s disease have depletions in similar types of beneficial bacteria, which could help explain the link between both conditions, a new microbiome study has found.
Date: 2025/03/20 - 00:00
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.
Date: 2025/03/18 - 23:31
Inflammation may be at the core of cognitive decline as recent studies offer clues on how herpes simplex virus-1, antibiotics, antivirals, and vaccines may have different effect on dementia risk.